Abstract
In spite of the fact that they occur at high rates, the clinical responses of BRAFV600 mutant metastatic melanoma to BRAF inhibitors are usually short-lasting, with most cases progressing within le...
Cite
CITATION STYLE
APA
Donia, M., Fagone, P., Nicoletti, F., Andersen, R. S., Høgdall, E., Straten, P. thor, … Svane, I. M. (2012). BRAF inhibition improves tumor recognition by the immune system. OncoImmunology, 1(9), 1476–1483. https://doi.org/10.4161/onci.21940
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free